Radiation	O
-	O
induced	O
Parotid	B:C0341045
Gland	I:C0341045
Atrophy	I:C0341045
in	O
Patients	O
with	O
Head	O
and	I:C0278996
Neck	I:C0278996
Cancer	I:C0278996
After	O
Carbon-ion	O
Radiotherapy	I:C3494442
.	O

Radiation	O
-	O
induced	O
Parotid	O
Gland	I:C0341045
Atrophy	I:C0341045
in	O
Patients	O
with	O
Head	B:C0278996
and	I:C0278996
Neck	I:C0278996
Cancer	I:C0278996
After	O
Carbon-ion	O
Radiotherapy	I:C3494442
.	O

Radiation	O
-	O
induced	O
Parotid	O
Gland	I:C0341045
Atrophy	I:C0341045
in	O
Patients	O
with	O
Head	O
and	I:C0278996
Neck	I:C0278996
Cancer	I:C0278996
After	O
Carbon-ion	B:C3494442
Radiotherapy	I:C3494442
.	O

This	O
study	B:C0008972
aimed	O
to	O
clarify	O
the	O
relationship	O
between	O
dosimetric	O
factors	O
and	O
parotid	O
gland	I:C0341045
(	I:C0341045
PG	I:C0341045
)	I:C0341045
atrophy	I:C0341045
after	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
(	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
)	O
.	O

This	O
study	O
aimed	O
to	O
clarify	O
the	O
relationship	O
between	O
dosimetric	B:C0034603
factors	O
and	O
parotid	O
gland	I:C0341045
(	I:C0341045
PG	I:C0341045
)	I:C0341045
atrophy	I:C0341045
after	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
(	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
)	O
.	O

This	O
study	O
aimed	O
to	O
clarify	O
the	O
relationship	O
between	O
dosimetric	O
factors	O
and	O
parotid	B:C0341045
gland	I:C0341045
(	I:C0341045
PG	I:C0341045
)	I:C0341045
atrophy	I:C0341045
after	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
(	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
)	O
.	O

This	O
study	O
aimed	O
to	O
clarify	O
the	O
relationship	O
between	O
dosimetric	O
factors	O
and	O
parotid	O
gland	I:C0341045
(	I:C0341045
PG	I:C0341045
)	I:C0341045
atrophy	I:C0341045
after	O
carbon	B:C3494442
ion	I:C3494442
radiotherapy	I:C3494442
(	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
)	O
.	O

This	O
study	O
aimed	O
to	O
clarify	O
the	O
relationship	O
between	O
dosimetric	O
factors	O
and	O
parotid	O
gland	I:C0341045
(	I:C0341045
PG	I:C0341045
)	I:C0341045
atrophy	I:C0341045
after	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
(	O
carbon	B:C3494442
ion	I:C3494442
radiotherapy	I:C3494442
)	O
.	O

Fifty	O
-	O
four	O
patients	O
with	O
head	B:C0018671
and	I:C0018671
neck	I:C0018671
tumours	I:C0018671
were	O
enrolled	O
and	O
93	O
irradiated	O
PGs	O
were	O
analyzed	O
.	O

Fifty	O
-	O
four	O
patients	O
with	O
head	O
and	I:C0018671
neck	I:C0018671
tumours	I:C0018671
were	O
enrolled	O
and	O
93	O
irradiated	O
PGs	B:C0030580
were	O
analyzed	O
.	O

Thirty	O
and	O
24	O
patients	O
were	O
treated	B:C0332293
with	I:C0332293
total	O
doses	O
[	O
relative	O
biological	O
effectiveness	O
(	O
RBE	O
)	O
]	O
of	O
57.6	O
Gy	O
and	O
64.0	O
Gy	O
,	O
respectively	O
,	O
in	O
16	O
fractions	O
.	O

parotid	B:C0030580
gland	I:C0030580
volumes	O
were	O
measured	O
using	O
computed	O
tomographic	O
images	O
obtained	O
before	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
and	O
every	O
3	O
-	O
6	O
months	O
thereafter	O
.	O

parotid	O
gland	I:C0030580
volumes	O
were	O
measured	B:C2700258
using	O
computed	O
tomographic	O
images	O
obtained	O
before	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
and	O
every	O
3	O
-	O
6	O
months	O
thereafter	O
.	O

parotid	O
gland	I:C0030580
volumes	O
were	O
measured	O
using	O
computed	O
tomographic	O
images	O
obtained	O
before	O
carbon	B:C3494442
ion	I:C3494442
radiotherapy	I:C3494442
and	O
every	O
3	O
-	O
6	O
months	O
thereafter	O
.	O

The	O
median	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
period	O
was	O
46.4	O
months	O
(	O
range	O
=24.0	O
-123.0	O
months	O
)	O
.	O

Univariate	O
analysis	O
showed	O
that	O
parotid	B:C0030580
gland	I:C0030580
volumes	O
receiving	O
more	O
than	O
5	O
,	O
10	O
,	O
15	O
,	O
and	O
20	O
Gy	O
RBE	O
(	O
V5	O
,	O
V10	O
,	O
V15	O
and	O
V20	O
,	O
respectively	O
)	O
,	O
mean	O
dose	O
,	O
and	O
maximum	O
dose	O
were	O
significantly	O
associated	O
with	O
PG	O
atrophy	I:C0341045
.	O

Univariate	O
analysis	O
showed	O
that	O
parotid	O
gland	I:C0030580
volumes	O
receiving	O
more	O
than	O
5	O
,	O
10	O
,	O
15	O
,	O
and	O
20	O
Gy	O
RBE	O
(	O
V5	O
,	O
V10	O
,	O
V15	O
and	O
V20	O
,	O
respectively	O
)	O
,	O
mean	O
dose	O
,	O
and	O
maximum	O
dose	O
were	O
significantly	O
associated	O
with	O
PG	B:C0341045
atrophy	I:C0341045
.	O

Multivariate	O
analysis	O
indicated	O
that	O
only	O
V5	O
was	O
significantly	O
associated	O
with	O
atrophy	B:C0341045
.	O

Increasing	O
V5	O
was	O
a	O
significant	O
risk	B:C0035648
factor	I:C0035648
for	O
PG	O
atrophy	I:C0341045
after	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
.	O

Increasing	O
V5	O
was	O
a	O
significant	O
risk	O
factor	I:C0035648
for	O
PG	B:C0341045
atrophy	I:C0341045
after	O
carbon	O
ion	I:C3494442
radiotherapy	I:C3494442
.	O

Increasing	O
V5	O
was	O
a	O
significant	O
risk	O
factor	I:C0035648
for	O
PG	O
atrophy	I:C0341045
after	O
carbon	B:C3494442
ion	I:C3494442
radiotherapy	I:C3494442
.	O

